Louisiana 2016 Regular Session

Louisiana House Bill HB613

Introduced
3/4/16  
Refer
3/4/16  
Refer
3/14/16  
Refer
3/14/16  
Report Pass
4/6/16  
Report Pass
4/6/16  
Engrossed
4/18/16  
Engrossed
4/18/16  
Refer
4/19/16  
Report Pass
4/27/16  
Report Pass
4/27/16  
Enrolled
5/4/16  
Enrolled
5/4/16  
Chaptered
5/10/16  
Chaptered
5/10/16  
Passed
5/10/16  

Caption

Provides relative to genetic information obtained by health insurers

Impact

The approval of HB 613 has implications for both health insurers and policyholders in Louisiana. By establishing clear guidelines for the use of genetic information, the bill is designed to protect individuals from discrimination based on their genetic makeup. This aligns state laws with federal standards, potentially simplifying compliance for insurers operating across multiple jurisdictions. However, the adjustments may also necessitate changes in how insurers manage and process genetic data, ensuring that they do so within the framework established by both state law and federal regulations.

Summary

House Bill 613 aims to regulate the use of genetic information obtained by health insurers in Louisiana. The bill enacts provisions that specifically outline exceptions to statutory requirements and restrictions related to the handling of such information. It emphasizes alignment with federal regulations, particularly the Health Insurance Portability and Accountability Act (HIPAA), which governs the privacy and security of health information. The legislation seeks to clarify scenarios under which genetic information may be utilized by insurers while maintaining compliance with existing healthcare laws.

Sentiment

The sentiment surrounding HB 613 appears to be largely supportive, especially among legislators focused on healthcare and insurance reform. Advocates argue that the bill fosters a more secure environment for the use of genetic information, which is increasingly relevant in healthcare discussions. However, there are concerns about the adequacy of the protections offered and whether the bill sufficiently addresses the potential for misuse or discrimination, highlighting a tension between innovation in healthcare and privacy rights.

Contention

Notable points of contention relate to how explicitly the bill protects against potential discrimination and whether the exemptions granted to insurers are overly broad. Although proponents argue that aligning state law with HIPAA strengthens consumer protections, critics worry that the exceptions enumerated in the bill—particularly those regarding treatment, payment, and healthcare operations—could undermine its intended protective purpose. Ensuring that the balance between advancing healthcare operations and preserving individual rights is maintained will be crucial as discussions around genetic information continue.

Companion Bills

No companion bills found.

Previously Filed As

LA HB455

Provides relative to the use of genetic information in underwriting for life and long-term care insurance

LA HB669

Provides relative to healthcare cost and quality information

LA HB412

Provides relative to reimbursement of noncontracted healthcare providers of emergency medical services

LA HB703

Provides relative to the use of genetic information in underwriting for life and long-term care insurance

LA SB2032

Relating To Genetic Information Privacy.

LA HB1058

Requires the Dept. of Health and Hospitals to provide information concerning Down syndrome to healthcare providers and on its website

LA HB502

AN ACT relating to genetic information.

LA SB19

Provides relative to criminal history record information obtained by the Louisiana State Board of Medical Examiners. (8/1/19) (EN SEE FISC NOTE SD EX See Note)

LA HB286

Requires life insurers to notify insureds relative to conversion option

LA HB521

Prohibits the use of genetic information relative to life and long-term care insurance

Similar Bills

No similar bills found.